Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

acute kidney injury

- PMLiVE

FDA knocks back Amgen’s chronic kidney disease treatment

Parsabiv was hoped to equal or exceed solid earner Sensipar

- PMLiVE

Updated EMPA-REG data show Jardiance also protects kidney

Boehringer Ingelheim and Lilly’s drug is the first to show positive impact on kidney damage

- PMLiVE

AZ and Inserm collaborate on diabetes and kidney disease

Three-year partnership will look at new therapeutic approaches

- PMLiVE

Atlantis Healthcare win grant for patient support programme

Programme will support chronic kidney disease

Sanofi reception

Generic competition for Sanofi’s Renvela hits UK market

Teva and others launch cheaper versions of the chronic kidney disease drug

Sanofi reception

Generic competition for Sanofi’s Renvela hits UK market

Teva and others launch cheaper versions of the chronic kidney disease drug

UK flag

Pharma firms open up drug libraries to UK researchers

AZ, GSK, Janssen, Lilly, Pfizer, Takeda and UCB partner with Medical Research Council

UK flag

Antimicrobial resistance priority for new UK science minister

Greg Clark announces collaboration led by Medical Research Council

- PMLiVE

BHF uses LEGO in first aid campaign

Uses toy to promote use of hands-only CPR

- PMLiVE

FDA panel turns down Otsuka’s drug for rare kidney disease

Unable to recommend expanded use of tolvaptan

Biogen Idec building

Biogen Idec signs brain research deal with Edinburgh University

Will identify potential treatments for multiple sclerosis and motor neurone disease

- PMLiVE

Publicis Life Brands Resolute coup at Creative Circle Awards

Honoured for campaign outside its healthcare speciality

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links